Head-To-Head Survey: Motus GI (NASDAQ:MOTS) versus SANUWAVE Health (OTCMKTS:SNWV)

Insider and Institutional Ownership

42.5% of SANUWAVE Health shares are held by institutional investors. Comparatively, 20.1% of Motus GI shares are held by institutional investors. 14.9% of SANUWAVE Health shares are held by company insiders. Comparatively, 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

SANUWAVE Health has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.

Profitability

This table compares SANUWAVE Health and Motus GI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SANUWAVE Health	-1.33%	-23.83%	-20.60%
Motus GI	N/A	N/A	N/A

Valuation & Earnings

This table compares SANUWAVE Health and Motus GI”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SANUWAVE Health	$41.28 million	6.93	-$25.81 million	($1.30)	-25.65
Motus GI	$319,000.00	0.00	-$12.87 million	($14.69)	0.00

Motus GI has lower revenue, but higher earnings than SANUWAVE Health. SANUWAVE Health is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

Summary

SANUWAVE Health beats Motus GI on 7 of the 11 factors compared between the two stocks.

About SANUWAVE Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

About Motus GI

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.